No such message found

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the Def-A

From the Def-A

posted on Jan 08, 2010 04:52PM
Mr. Flowers is entitled to a change in control payment should the surviving company not retain him after a merger or acquisition, additionally all of his unvested stock options vest and become exercisable as of the date of the change in control. A lump sum payment is to be made by us to Mr. Flowers as specified in the Flowers Agreement.

The table below was prepared as though a Change in Control occurred and Mr. Flowers’ employment was terminated on May 31, 2009.
Change in Control Payment Estimate
May 31, 2009
Name
Severance Pay ($)
Stock Options
(Black-Scholes Value)
($)
Total ($)
Clifford L. Flowers
$
115,875
$
110,321
$
226,196
Share
New Message
Please login to post a reply